- Home
- NXGL vs CCM Comparison
NXGL vs CCM Comparison
Compare NXGL & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXGL
- CCM
- Stock Information
- Founded
- NXGL 1997
- CCM 1997
- Country
- NXGL United States
- CCM China
- Employees
- NXGL N/A
- CCM N/A
- Industry
- NXGL Medical/Dental Instruments
- CCM Medical/Nursing Services
- Sector
- NXGL Health Care
- CCM Health Care
- Exchange
- NXGL Nasdaq
- CCM Nasdaq
- Market Cap
- NXGL 18.9M
- CCM 18.2M
- IPO Year
- NXGL 2021
- CCM 2009
- Fundamental
- Price
- NXGL $2.70
- CCM $4.73
- Analyst Decision
- NXGL
- CCM
- Analyst Count
- NXGL 0
- CCM 0
- Target Price
- NXGL N/A
- CCM N/A
- AVG Volume (30 Days)
- NXGL 36.7K
- CCM 29.8K
- Earning Date
- NXGL 05-12-2025
- CCM 05-02-2025
- Dividend Yield
- NXGL N/A
- CCM N/A
- EPS Growth
- NXGL N/A
- CCM N/A
- EPS
- NXGL N/A
- CCM N/A
- Revenue
- NXGL $8,688,000.00
- CCM $64,910,622.00
- Revenue This Year
- NXGL $51.39
- CCM N/A
- Revenue Next Year
- NXGL $36.14
- CCM N/A
- P/E Ratio
- NXGL N/A
- CCM N/A
- Revenue Growth
- NXGL 112.47
- CCM N/A
- 52 Week Low
- NXGL $1.84
- CCM $3.80
- 52 Week High
- NXGL $5.10
- CCM $26.70
- Technical
- Relative Strength Index (RSI)
- NXGL 46.52
- CCM 58.04
- Support Level
- NXGL $2.54
- CCM $3.88
- Resistance Level
- NXGL $2.99
- CCM $4.55
- Average True Range (ATR)
- NXGL 0.26
- CCM 0.39
- MACD
- NXGL 0.01
- CCM 0.07
- Stochastic Oscillator
- NXGL 62.43
- CCM 84.16
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.